RT @mbeyp2: Metanálisis de terapias inhaladas en EPOC, muy interesante !!!@SEMERGENap @EdSEMERGEN @rafamanuEl68 @KINGPERITA @semergenpv @SE…
Metanálisis de terapias inhaladas en EPOC, muy interesante !!!@SEMERGENap @EdSEMERGEN @rafamanuEl68 @KINGPERITA @semergenpv @SEMERGEN_CV @Sonia_MJ #COPD #epoc #inhaladoresEPOC https://t.co/Di7zNhHWyF
RT @Students4BE: New @CochraneAirways evidence from a network meta-analysis on long-acting inhalers for people with COPD https://t.co/94RwG…
RT @Students4BE: New @CochraneAirways evidence from a network meta-analysis on long-acting inhalers for people with COPD https://t.co/94RwG…
New @CochraneAirways evidence from a network meta-analysis on long-acting inhalers for people with COPD https://t.co/94RwGUMMar @CochraneUK #COPD
RT @CochraneUK: New @CochraneAirways evidence from a network meta-analysis on long-acting inhalers for people with COPD: https://t.co/bMgmC…
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: New evidence from a network meta-analysis on long-acting inhalers for people with #COPD https://t.co/L7ffvHXClY @Cochr…
RT @CochraneAirways: New evidence from a network meta-analysis on long-acting inhalers for people with #COPD https://t.co/L7ffvHXClY @Cochr…
New evidence from a network meta-analysis on long-acting inhalers for people with #COPD https://t.co/L7ffvHXClY @CochraneUK #CochraneEvidence https://t.co/xnxMtsCqgr
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: ICS‐containing inhalers are associated with an increased risk of pneumonia https://t.co/hZ2gnXK0An [4/4]
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
Terapia broncodilatadora dual vs broncodilatador de larga duración en EPOC: 👉99 estudios (101,000 sujetos) 👉La combinación LAMA/LABA fue mejor para prevenir exacerbaciones, mejorar síntomas y calidad de vida 👉 La combinación con ICS ⬆️riesgo de neumonía ht
RT @tlassers: Loud haler for inhalers: Combination treatments of #COPD compared in new #NetworkMetaAnalysis https://t.co/uV3gRg0QM0 https:/…
Loud haler for inhalers: Combination treatments of #COPD compared in new #NetworkMetaAnalysis https://t.co/uV3gRg0QM0
RT @CochraneAirways: ICS‐containing inhalers are associated with an increased risk of pneumonia https://t.co/hZ2gnXK0An [4/4]
RT @CochraneAirways: So how big was this review? Well it had 99 studies and 101,000 people. It incorporated a network meta-analysis which c…
ICS‐containing inhalers are associated with an increased risk of pneumonia https://t.co/hZ2gnXK0An [4/4]
So how big was this review? Well it had 99 studies and 101,000 people. It incorporated a network meta-analysis which can rank a number of treatments and 6 pairwise comparisons https://t.co/hZ2gnXK0An
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
LAMA/LABA preferable over LAMA or LABA ICS combinations for high risk COPDers. Good to know 👍
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
RT @CochraneAirways: Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for…
Here it is in all it's glory! #CochraneEvidence: Dual combination therapy versus long‐acting bronchodilators alone for chronic obstructive pulmonary disease (COPD): a systematic review and network meta‐analysis https://t.co/hZ2gnXK0An